Home
Conditions
Tardive Dyskinesia

Clinical trial condition

Tardive Dyskinesia

Explore clinical trials studying Tardive Dyskinesia. Study availability and eligibility vary by location and protocol.

34 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Tardive Dyskinesia trial results

Completed

Xenazine in Late Dyskinetic Syndrome With Neuroleptics

NCT01543321

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: CHU Amiens Amiens, Picardie, France

CH Aix en Provence Aix-en-Provence, France

CHU Bordeaux Bordeaux, France

CHU Caen Caen, France

View all 19 locations

View Trial Details

Completed

Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets

NCT06474650

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Shanghai Mental Health Center Shanghai, China

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects

NCT06216054

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Shanghai Mental Health Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

NCT05238701

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Shanghai Mental Health Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

NCT03287778

Conditions: Antipsychotic Agents, Central Nervous System Diseases, Dyskinesia, Drug-Induced, +10 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

NCT03497013

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +9 more
Locations: Suzhou Psychiatric Hospital Suzhou, Jiangsu, China

Suzhou Suzhou, Jiangsu, China

View Trial Details

Completed

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

NCT02198794

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Teva Investigational Site 145 Tuscaloosa, Alabama, United States

Teva Investigational Site 107 Anaheim, California, United States

Teva Investigational Site 108 Anaheim, California, United States

Teva Investigational Site 123 Glendale, California, United States

View all 82 locations

View Trial Details

Completed

Aim to Reduce Movements in Tardive Dyskinesia

NCT02195700

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Tuscaloosa, Alabama, United States

Anaheim, California, United States

Glendale, California, United States

Oceanside, California, United States

View all 41 locations

View Trial Details

Completed

Pimavanserin Treatment in TS

NCT04794413

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Baylor College of Medicine Houston, Texas, United States

View Trial Details

Completed

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

NCT02736955

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Anaheim, California, United States

National City, California, United States

Norwalk, California, United States

Oakland, California, United States

View all 27 locations

View Trial Details

Tardive Dyskinesia

Tardive Dyskinesia trial results

Related conditions